Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Procedure for unmasking localization information from ProstaScint scans for prostate radiation therapy treatment planning
New York University.
New York University, Department of Radiology. (Nuclear Medicine)
New York University.
New York University, Department of Radiology.
Vise andre og tillknytning
2004 (engelsk)Inngår i: International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, E-ISSN 1879-355X, Vol. 60, nr 2, s. 654-662Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Purpose: To demonstrate a method to extract the meaningful biologic information from In-111-radiolabeled capromab pendetide (ProstaScint) SPECT scans for use in radiation therapy treatment planning by removing that component of the In-111 SPECT images associated with normal structures. Methods and Materials: We examined 20 of more than 80 patients who underwent simultaneous Tc-99m/In-111 SPECT scans, which were subsequently registered to the corresponding CT/MRI scans. A thresholding algorithm was used to identify Tc-99m uptake associated with blood vessels and CT electron density associated with bone marrow. Corresponding voxels were removed from the In-111 image set. Results: No single threshold value was found to be associated with the Tc-99m uptake that corresponded to the blood vessels. Intensity values were normalized to a global maximum and, as such, were dependent upon the quantity of Tc-99m pooled in the bladder. The reduced ProstaScint volume sets were segmented by use of a thresholding feature of the planning system and superimposed on the CT/MRI scans. Conclusions: ProstaScint images are now closer to becoming a biologically and therapeutically useful and accurate image set. After known sources of normal intensity are stripped away, the remaining areas that demonstrate uptake may be segmented and superimposed on the treatment-planning CT/MRI volume.

sted, utgiver, år, opplag, sider
2004. Vol. 60, nr 2, s. 654-662
Emneord [en]
ProstaScint, volume fusion, volume subtraction, prostate cancer treatment planning, radioimmunoguided therapy, in-111 capromab pendetide, volume data sets, dose-escalation, image registration, magnetic-resonance, 3-dimensional registration, conformal radiotherapy, cancer, fusion, brain
HSV kategori
Forskningsprogram
SRA - Informations- och kommunikationsteknik
Identifikatorer
URN: urn:nbn:se:kth:diva-23735DOI: 10.1016/j.ijrobp.2004.05.034ISI: 000223966500039PubMedID: 15380603Scopus ID: 2-s2.0-4544380881OAI: oai:DiVA.org:kth-23735DiVA, id: diva2:342434
Merknad

QC 20100525 QC 20110922 QC 20150630 44th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology. NEW ORLEANS, LA. OCT 06-10, 2002

Tilgjengelig fra: 2010-08-10 Laget: 2010-08-10 Sist oppdatert: 2020-03-09bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Maguire Jr., Gerald Q.

Søk i DiVA

Av forfatter/redaktør
Maguire Jr., Gerald Q.
Av organisasjonen
I samme tidsskrift
International Journal of Radiation Oncology, Biology, Physics

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 193 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf